The rate of congenital malformations after first-trimester exposure to itra
conazole was four times higher when ascertained retrospectively than prospe
ctively (13.0 vs 3.2%, p = 0.006). Reporting bias in retrospective studies
should be acknowledged in interpretation of such data.